CVS Health Corporation (NYSE:CVS) Receives $94.67 Average Target Price from Brokerages

CVS Health Corporation (NYSE:CVS) has been given an average rating of “Moderate Buy” by the twenty-six ratings firms that are presently covering the stock, MarketBeat.com reports. Four analysts have rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating on the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $94.8571.

CVS has been the topic of a number of recent analyst reports. Robert W. Baird boosted their target price on CVS Health from $82.00 to $92.00 and gave the stock an “outperform” rating in a research report on Wednesday, December 10th. Truist Financial set a $100.00 price objective on shares of CVS Health in a research note on Wednesday, December 10th. Royal Bank Of Canada reissued an “outperform” rating on shares of CVS Health in a research report on Thursday, December 4th. Sanford C. Bernstein restated a “market perform” rating and issued a $91.00 price target on shares of CVS Health in a research report on Tuesday. Finally, Leerink Partners lifted their price objective on shares of CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a research report on Thursday, October 16th.

Hedge Funds Weigh In On CVS Health

Several institutional investors and hedge funds have recently bought and sold shares of CVS. Norges Bank acquired a new stake in shares of CVS Health during the second quarter worth approximately $1,358,698,000. Wellington Management Group LLP lifted its position in CVS Health by 391.6% in the 3rd quarter. Wellington Management Group LLP now owns 6,330,717 shares of the pharmacy operator’s stock worth $477,273,000 after buying an additional 5,042,816 shares in the last quarter. Amundi boosted its stake in shares of CVS Health by 95.3% during the 3rd quarter. Amundi now owns 7,453,980 shares of the pharmacy operator’s stock valued at $572,665,000 after buying an additional 3,637,943 shares during the period. Invesco Ltd. grew its holdings in shares of CVS Health by 15.3% during the 2nd quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock valued at $1,623,270,000 after acquiring an additional 3,118,626 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. raised its holdings in shares of CVS Health by 815.2% during the second quarter. Robeco Institutional Asset Management B.V. now owns 2,663,111 shares of the pharmacy operator’s stock worth $183,701,000 after acquiring an additional 2,372,121 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

Shares of CVS opened at $80.29 on Friday. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63. The firm’s 50 day moving average is $78.70 and its 200-day moving average is $73.88. CVS Health has a 12-month low of $46.34 and a 12-month high of $85.15. The stock has a market capitalization of $101.92 billion, a P/E ratio of 211.29, a P/E/G ratio of 0.74 and a beta of 0.48.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. The firm had revenue of $102.87 billion during the quarter, compared to analysts’ expectations of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same period last year, the firm posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Equities research analysts anticipate that CVS Health will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd will be issued a dividend of $0.665 per share. The ex-dividend date is Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.3%. CVS Health’s payout ratio is currently 700.00%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.